Logo image of SQNS

SEQUANS COMMUNICATIONS-ADR (SQNS) Stock Fundamental Analysis

USA - NYSE:SQNS - US8173233060 - ADR

9.84 USD
-0.49 (-4.74%)
Last: 9/19/2025, 8:04:00 PM
9.85 USD
+0.01 (+0.1%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, SQNS scores 4 out of 10 in our fundamental rating. SQNS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. SQNS has only an average score on both its financial health and profitability. SQNS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SQNS had positive earnings in the past year.
SQNS had a negative operating cash flow in the past year.
In the past 5 years SQNS reported 4 times negative net income.
SQNS had a negative operating cash flow in each of the past 5 years.
SQNS Yearly Net Income VS EBIT VS OCF VS FCFSQNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

The Return On Assets of SQNS (61.05%) is better than 99.11% of its industry peers.
SQNS has a better Return On Equity (129.98%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 61.05%
ROE 129.98%
ROIC N/A
ROA(3y)2.44%
ROA(5y)-15.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQNS Yearly ROA, ROE, ROICSQNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

SQNS's Profit Margin of 144.41% is amongst the best of the industry. SQNS outperforms 100.00% of its industry peers.
SQNS's Gross Margin of 70.17% is amongst the best of the industry. SQNS outperforms 91.96% of its industry peers.
In the last couple of years the Gross Margin of SQNS has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 144.41%
GM 70.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
SQNS Yearly Profit, Operating, Gross MarginsSQNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

More info and screens

4

2. Health

2.1 Basic Checks

SQNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SQNS has been increased compared to 1 year ago.
Compared to 5 years ago, SQNS has more shares outstanding
The debt/assets ratio for SQNS has been reduced compared to a year ago.
SQNS Yearly Shares OutstandingSQNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
SQNS Yearly Total Debt VS Total AssetsSQNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

SQNS has an Altman-Z score of 18.08. This indicates that SQNS is financially healthy and has little risk of bankruptcy at the moment.
SQNS's Altman-Z score of 18.08 is amongst the best of the industry. SQNS outperforms 86.61% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that SQNS is not too dependend on debt financing.
SQNS has a Debt to Equity ratio of 0.11. This is comparable to the rest of the industry: SQNS outperforms 53.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 18.08
ROIC/WACCN/A
WACC10.79%
SQNS Yearly LT Debt VS Equity VS FCFSQNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 1.83 indicates that SQNS should not have too much problems paying its short term obligations.
SQNS's Current ratio of 1.83 is on the low side compared to the rest of the industry. SQNS is outperformed by 77.68% of its industry peers.
A Quick Ratio of 1.75 indicates that SQNS should not have too much problems paying its short term obligations.
SQNS has a worse Quick ratio (1.75) than 66.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.75
SQNS Yearly Current Assets VS Current LiabilitesSQNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 256.55% over the past year.
Looking at the last year, SQNS shows a very strong growth in Revenue. The Revenue has grown by 32.05%.
SQNS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.60% yearly.
EPS 1Y (TTM)256.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.22%
Revenue 1Y (TTM)32.05%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%-15.84%

3.2 Future

The Earnings Per Share is expected to decrease by -26.75% on average over the next years. This is quite bad
Based on estimates for the next years, SQNS will show a very strong growth in Revenue. The Revenue will grow by 20.27% on average per year.
EPS Next Y-148.4%
EPS Next 2Y-48.9%
EPS Next 3Y-26.75%
EPS Next 5YN/A
Revenue Next Year-18.4%
Revenue Next 2Y24.21%
Revenue Next 3Y20.27%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SQNS Yearly Revenue VS EstimatesSQNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SQNS Yearly EPS VS EstimatesSQNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.33, the valuation of SQNS can be described as very cheap.
SQNS's Price/Earnings ratio is rather cheap when compared to the industry. SQNS is cheaper than 99.11% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.38, SQNS is valued rather cheaply.
SQNS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 4.33
Fwd PE N/A
SQNS Price Earnings VS Forward Price EarningsSQNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SQNS Per share dataSQNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

A cheap valuation may be justified as SQNS's earnings are expected to decrease with -26.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-48.9%
EPS Next 3Y-26.75%

More info and screens

0

5. Dividend

5.1 Amount

SQNS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEQUANS COMMUNICATIONS-ADR

NYSE:SQNS (9/19/2025, 8:04:00 PM)

After market: 9.85 +0.01 (+0.1%)

9.84

-0.49 (-4.74%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners18.36%
Inst Owner Change289.08%
Ins Owners1.05%
Ins Owner ChangeN/A
Market Cap1.40B
Analysts82.5
Price TargetN/A
Short Float %N/A
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.83%
Min EPS beat(2)-1.2%
Max EPS beat(2)18.86%
EPS beat(4)2
Avg EPS beat(4)216.6%
Min EPS beat(4)-12.04%
Max EPS beat(4)860.78%
EPS beat(8)4
Avg EPS beat(8)101.43%
EPS beat(12)7
Avg EPS beat(12)80.87%
EPS beat(16)11
Avg EPS beat(16)71.46%
Revenue beat(2)1
Avg Revenue beat(2)-19.25%
Min Revenue beat(2)-48.17%
Max Revenue beat(2)9.67%
Revenue beat(4)3
Avg Revenue beat(4)17.48%
Min Revenue beat(4)-48.17%
Max Revenue beat(4)105.88%
Revenue beat(8)4
Avg Revenue beat(8)-0.97%
Revenue beat(12)5
Avg Revenue beat(12)-1.82%
Revenue beat(16)5
Avg Revenue beat(16)-2.04%
PT rev (1m)-26.67%
PT rev (3m)-26.67%
EPS NQ rev (1m)40%
EPS NQ rev (3m)21.74%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.3%
Revenue NQ rev (1m)-30.52%
Revenue NQ rev (3m)-37.06%
Revenue NY rev (1m)-13.64%
Revenue NY rev (3m)-17.49%
Valuation
Industry RankSector Rank
PE 4.33
Fwd PE N/A
P/S 37.62
P/FCF N/A
P/OCF N/A
P/B 33.87
P/tB 49.54
EV/EBITDA N/A
EPS(TTM)2.27
EY23.07%
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.26
BVpS0.29
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 61.05%
ROE 129.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 144.41%
GM 70.17%
FCFM N/A
ROA(3y)2.44%
ROA(5y)-15.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.17%
Cap/Sales 13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.75
Altman-Z 18.08
F-Score5
WACC10.79%
ROIC/WACCN/A
Cap/Depr(3y)234.19%
Cap/Depr(5y)223.55%
Cap/Sales(3y)59.67%
Cap/Sales(5y)52.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)256.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.22%
EPS Next Y-148.4%
EPS Next 2Y-48.9%
EPS Next 3Y-26.75%
EPS Next 5YN/A
Revenue 1Y (TTM)32.05%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%-15.84%
Revenue Next Year-18.4%
Revenue Next 2Y24.21%
Revenue Next 3Y20.27%
Revenue Next 5YN/A
EBIT growth 1Y8.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y21.52%
EBIT Next 5YN/A
FCF growth 1Y-94.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6553.81%
OCF growth 3YN/A
OCF growth 5YN/A